Home / Resource Library / Brutons tyrosine kinase inhibitors in diffuse large B-cell lymphoma therapy: critical considerations and future innovations

Brutons tyrosine kinase inhibitors in diffuse large B-cell lymphoma therapy: critical considerations and future innovations

Article discusses clinical trials for BTK inhibitors in DLBCL.